Mechanism of the regulation of organic cation/carnitine transporter 1 (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines

Drug Metabolism and Disposition

Volumn 35, Issue 3, 2007, Pages 394-401

  Maeda, Tomoji ^a   Hirayama, Masamichi ^a   Kobayashi, Daisuke ^a   Miyazawa, Keiji ^b   Tamai, Ikumi ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LUCIFERASE; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 4; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIOCYTE; TRANSCRIPTION INITIATION SITE;

ARTHRITIS, RHEUMATOID; BINDING SITES; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; HUMANS; INTERLEUKIN-1BETA; MUTATION; NF-KAPPA B; ORGANIC CATION TRANSPORT PROTEINS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 33847411467     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.012112     Document Type: Article

References (42)

1. Arend WP and Dayer J-M (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160.
2. Barchowsky A, Frleta D, and Vincenti MP (2000) Integration of the NF-κB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 12:1469-1479.
3. Buchan G, Barrett K, Fujita T, Taniguchi T, Maini R, and Feldmann M (1988) Detection of activated T cell products in the rheumatoid joint using cDNA probes to interleukin-2 (IL-2) IL-2 receptor and IFN-γ. Clin Exp Immunol 71:295-301.
4. Colognato R, Laurenza I, Fontana I, Coppede F, Siciliano G, Coecke S, Aruoma OI, Benzi L, and Migliore L (2006) Modulation of hydrogen peroxide-induced DNA damage, MAPKs activation and cell death in PC12 by ergothioneine. Clin Nutr 25:135-145.
5. Dendorfer U, Oettgen P, and Libermann TA (1994) Multiple regulation elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 14:4443-4454.
6. Feldmann M, Brennan FM, and Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397-440.
7. Firestein GS, Alvaro-Garcia JM, and Maki R (1990) Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144:3347-3353.
8. Gazouli M, Mantzaris G, Archimandritis AJ, Nasioulas G, and Anagnou NP (2005) Signal nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. World J Gastroenterol 11:7525-7530.
9. 2 dissociates nuclear trafficking of individual NF-κB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts. J Immunol 175:6924-6930.
10. Grundemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, and Schomig E (2005) Discovery of the ergothioneine transporter. Proc Natl Sci USA 102:5256-5261.
11. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Wright JA, Robarge J, Ott J, et al. (2003) A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 35:349-356.
12. Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, Akiyoshi M, Yoshida M, and Nakamura T (2006) Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1β-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-κB and p38. Rheumatology 45:824-832.
13. Huang C, Bi E, Hu Y, Deng W, Tian Z, Dong C, Hu Y, and Sun B (2006) A novel NF-κB binding site controls human granzyme B gene transcription. J Immunol 176:4173-4181.
14. Jackson JR, Minton JA, Ho ML, Wei N, and Winkler JD (1997) Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β. J Rheumatol 24:1253-1259.
15. Kadonaga JT, Carner KR, Masiarz FR, and Tjian R (1987) Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079-1090.
16. Kobayashi D, Aizawa S, Maeda T, Tsuboi I, Yabuuchi H, Nezu J, Tsuji A, and Tamai I (2004) Expression of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation. Exp Hematol 32:1156-1162.
17. Lutterbach B and Heibert SW (2000) Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245:223-235.
18. Maeda T, Hirayama M, Kobayshi D, and Tamai I (2005) Regulation of testis-specific carnitine transporter (octn3) gene by proximal cis-acting elements Sp1 in mice. Biochem Pharmacol 70:858-868.
19. McClure RF, Heppelmann CJ, and Paya CV (1999) Constitutive Fas ligand gene transcription in Sertoli cells is regulated by Sp1. J Biol Chem 274:7756-7762.
20. Miyazawa K, Mori A, and Okudaira H (1998) Establishment and characterization of novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J Biochem 124:1153-1162.
21. Miyazawa K, Mori A, Yamamoto K, and Okudaira H (1998) Transcriptional roles of CCAAT/enhancer binding protein- β, nuclear factor-κB, and C-promoter binding factor 1 in interleukin (IL)-1β-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes. J Biol Chem 273:7620-7627.
22. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
23. Okuda T, van Deursen J, Hiebert SW, Grosveld G, and Downing JR (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330.
24. Panayi GS, Lanchbury JS, and Kingsley GH (1992) The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735.
25. Ozturk HS, Cimen MYB, Cimen OB, Kacmaz M, and Durak I (1999) Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 19; 35-37.
26. Peltekova V, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Oene MV, Cescon D, Greenberg G, et al. (2004) Functional variants of OCTN1 cation transporter genes are associated with Crohn disease. Nat Genet 36:471-475.
27. Pillinger MH, Rosenthal PB, Tolani SN, Apsel B, Dinsell V, Greenberg J, Chan ESL, Gomez PF, and Abramson SB (2003) Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation. J Immunol 171:6080-6089.
28. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdottir H, Grondal G, et al. (2002) A regulatory polymorphism PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32:666-669.
29. Ray A, Schatten H, and Ray BK (1999) Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J Biol Chem 274:4300-4308.
30. Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, and Preudhomme C (2003) New mechanisms of AML1 gene alteration in hematological malignancies. Leukemia 17:9-16.
31. Russell RK, Drummond H, Nimmo E, Anderson N, Noble C, Wilson D, Gillett P, McGrogen P, Hassan K, Weaver L, et al. (2006) Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth parameters in early-onset inflammatory bowel disease. Gut 55:1114-1123.
32. Saffer JD, Jackson SP, and Annarella MB (1991) Developmental expression of Sp1 in the mouse. Mol Cell Biol 11:2189-2199.
33. Schreiber E, Matthias P, Muller MM, and Schaffner W (1989) Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells. Nucleic Acids Res 17:6419.
34. Suzuki M, Oda E, Nakajima T, Sekiya S, and Oda K (1998) Induction of Sp1 in differentiating human embryonal carcinoma cells triggers transcription of the fibronectin gene. Mol Cell Biol 18:3010-3020.
35. Tamai I, Nakanishi T, Kobayashi D, China K, Kosugi Y, Nezu J, Sai Y, and Tsuji A (2003) Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol Pharmacol 1:57-66.
36. Tamai I, Ohashi R, Nezu J, Sai Y, Kobayashi D, Oku A, Shimane M, and Tsuji A (2000) Molecular and function characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064-40072.
37. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, and Tsuji A (1998) Molecular and function identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378-20382.
38. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, and Tsuji A (1997) Cloning and characterization of novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111.
39. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, et al. (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35:341-348.
40. Tomita T, Takano H, Tomita N, Morishita R, Kaneko M, Shi K, Takahi K, Nakase Y, Kaneda H, Yoshikawa H, et al. (2000) Transcription factor decoy for NFκB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. Rhematology 39:749-757.
41. Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, and Tsuji A (1999) Novel member transporter OCTN1 mediates multispecific, bi-directional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289:768-773.
42. Yamazaki K, Takazoe M, Tanaka T, Ichimori T, Saito S, Iida A, Onouchi Y, Hata A, and Nakamura Y (2004) Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J Hum Genet 49:664-668.